Leukemia Survivors' immunity under the microscope
NCT ID NCT05622682
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study followed 89 children who finished chemotherapy for acute lymphoblastic leukemia (ALL) to see how their immune systems bounced back. Researchers measured antibody levels for vaccine-preventable diseases and tracked infections during the first year off treatment. The goal is to learn whether kids need extra vaccine doses after leukemia therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors know when to give extra vaccines to children after leukemia treatment, reducing infection risk.
- What could go wrong
- This is an observational study, not a treatment trial. It gathers information but does not test a new therapy, so it won't directly change care yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
CHRISTUS Children's (Affiliate of Baylor College of Medicine)
San Antonio, Texas, 78207, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503, United States
-
Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, 37232, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can donor immune cells tame stem cell transplant risks?
- Can we make CAR-T cells last longer in leukemia?
- A simple blood draw could spare kids with leukemia from painful bone marrow tests